Compare Reddit Inc (RDDT) vs Summit Therapeutics Inc (SMMT) Price & Performance

Reddit (RDDT) trades at $156.49, up 2.44% today, showing strong momentum after recent earnings beats. The stock maintains a bullish technical outlook with support at $154 and resistance at $158. Fundamentally, the company demonstrates exceptional profitability with 91.44% gross margins and 31.35% net income margins, though valuation metrics remain elevated with a P/E of 36.39. Recent news highlights strategic partnerships and international expansion driving growth.

Outlook remains positive with analyst consensus at $202.52 (29% upside) and 65% buy ratings. Key opportunities include AI data licensing growth and international monetization, while risks involve competitive pressures and potential valuation compression given premium multiples. The company's transition to profitability and strong cash flow generation support continued expansion.

Summit Therapeutics (SMMT) trades at $17.17, down 4.35% on the day, amid mixed technical signals with a bullish moving average trend but neutral oscillators. The company reported no revenue in 2025 and a net loss of $1.08 billion, with negative ROE and ROA, yet maintains a high P/B ratio of 21.76. Recent positive sentiment is driven by a $2 billion strategic investment from AstraZeneca and expanded clinical collaborations for its lead drug ivonescimab, as reported by Reuters and Business Wire on September 28-29, 2026.

The outlook hinges on clinical success; upside exists if ivonescimab trials meet endpoints, supported by strong analyst consensus (65% buy rating) and a $29.33 price target. Key risks include cash burn from negative operating cash flow, drug development failures, and reliance on partnership outcomes, posing significant volatility for investors despite institutional interest.